[Reference: http://clinicaltrials.gov/ct2/show/NCT01182324?term=ataluren&rank=10 ]     Purpose The traditional process for the development of new potential therapeutics for rare disorders and the ensuing research on safety and efficacy is changing. This is due, in part, to the increased ability of families, parents, individuals with rare disorders, and advocacy organizations to access and con…